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Abstract
Background: Tuberculosis remains a major public health problem in Ethiopia. In 2010 the TB treatment regimen
was shortened from 8 to 6-months treatment. With this new regimen, the full course of treatment should be taken
under Directly Observed Therapy (DOT) unlike the 8-month regimen where TB patients were only observed during
the intensive phase, this has not been tried before and may be difficult to implement. Therefore this study aimed
to investigate the experiences from both TB patients and health care providers’ perspective of implementing DOT
for the full course of TB treatment.
Methods: Qualitative study consisted of 11 in-depth interviews and 4 Focus Group Discussions (FDGs) were conducted
between March and April, 2014. Overall, 18 TB patients and 16 HCPs were involved from three selected public health
facilities (2 Health Centers and 1 Hospital) in Addis Ababa, Ethiopia. Qualitative data analysis software (Open Code
Version 3.5) was employed to identify the key issues from these interviews through coding, categorization and grouping
into emergent themes.
Results: Participants reported that making a daily visit to health facilities for DOT was difficult due to the distance of the
facilities from their residences, lack of or high transportation cost and had undesired implications on their work and
social lives. TB patients had to overcome many challenges to comply with TB treatment on a daily basis. HCPs also
indicated the difficulties of implementing facility based daily DOT mainly due the implication it had on their TB patients
and stated DOT had not always been implemented for the full course as recommended. HCPs also shared deep concern
regarding the risk of acquiring multiple drug resistant TB.
Conclusion: This study indicated there are several challenges associated with facility based daily DOT as a method of TB
treatment supervision in public health facilities in Addis Ababa. This may be indicative of the situation in other health
facilities in Addis Ababa as well as elsewhere in the country. Hence the TB control program has to explore how best to
improve TB treatment delivery options to ensure adequate treatment. A more patient-centered approach could be
strengthened by further decentralizing the DOT to the community level in order to ensure adherence of patients to
their TB treatment.
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Background
Tuberculosis (TB) remains a major global health problem.
About a third of the world’s population is estimated to be
infected with Mycobacterium tuberculosis. Ethiopia stands
7th among the 22 High-Burden Countries (HBCs) and
these countries account for about 80 % of the world's TB
cases [1, 2]. In Addis Ababa, the principal city of Ethiopia,
TB is also a major public health concern [3]. The National
Tuberculosis Program (NTP) efforts to control TB in
Ethiopia began in the early 1960s through the adop-
tion and implementation of different internationally
recommended TB control strategies. Ethiopia has been
implementing the World Health Organization (WHO)
recommended TB control strategy known as Directly Ob-
served Treatment Short- Course (DOTS) since 1991 and
also adopted the WHO Stop TB Strategy since 2006 [4].
Since the year 2004 WHO recommended all countries
and settings to change their TB treatment from 8-month
to 6-month with the shift of the continuation phase of
the anti-TB regimen from Ethambutol and Isoniazid
(EH) based regimen to Rifampicin and Isoniazid (RH)
based regimen. Hence, the full course of treatment is ex-
pected to be directly observed [5, 6]. This recommenda-
tion was based on the trial of the International Union
Against Tuberculosis and Lung Disease (The Union)
demonstrating increased efficacy of the 6-month regi-
men and was shown to be clinically superior to the 8-
month regimen [7] also the 8-month regimen was asso-
ciated with more relapses and deaths than the 6-month
regimen [8]. In addition, shorter regimens for drug-
susceptible TB may increase adherence, reduce default,
attract more TB patients, and bring higher effective cure
rates and fewer new cases of multiple drug-resistant TB
(MDR-TB). Therefore, the identification of lengthy regi-
mens as a problem and treatment shortening as a global
goal have been formalized by the Stop TB Partnership in
the Global Plan 2006–2015 [2]. However of the 22 HBCs
Ethiopia and Nigeria delayed the change from the 8-
month to the 6-month regimen and the main reasons re-
ported were primarily due to a perceived lack of strong
DOT, fear of poor adherence and thus concern about in-
creasing Rifampicin resistance [9].
But since September 2010, the Ethiopian Federal Minis-
try of Health, decided to implement the regimen change
across the country in a phased manner and the regimen
change was initially piloted in selected facilities found in
three urban regions of the country which was followed by
full scale-up into all the public health facilities in the
country with strong consideration for implementation of
DOT for the whole six month duration of patients treat-
ment [4, 10]. DOT that is watching the patient swallow
every scheduled dose, in the right doses and at the right
intervals, is the most effective method to promote treat-
ment adherence and gives individual TB patients the best
chance of cure and also avoids the emergence of drug re-
sistance [11]. With this new regimen, the full course of
treatment should be taken under DOT to make sure pa-
tients are taking all the prescribed drugs. This means pa-
tients should be observed while taking their medications
on daily basis by TB Treatment Supporters (TTS) for the
full six months of treatment duration, unlike the previous
regimen where TB patients were only observed during the
intensive phase during the first two months of their treat-
ment and this has not been tried before and might have
some consequences as it may be difficult for all TB pa-
tients to be observed while taking each dose of their medi-
cations every day for the total duration of their treatment.
Therefore this study aimed to explore the experiences
from both patients and health care providers (HCPs) of
implementing DOT for the full course of TB treatment in




The study was conducted in three selected public health
facilities (two health centers and one hospital) found in
Addis Ababa, the principal city of the Federal Demo-
cratic Republic of Ethiopia. Addis Ababa has a projected
total population of 3,272,237 (52 % Female and 48 %
Male) in the year 2014/15 and the HIV prevalence
among adult population in 2011 was 5.2 %. In the city
there were a total of 102 public health facilities (88
Health centers and 14 hospitals including federal, police
and defense hospitals) providing TB diagnosis and treat-
ment services [3] and in total 24.8 % of all households
are considered overcrowded [12].
Study design
A qualitative study method consisted of 11 in-depth in-
terviews and 4 focus group discussions (FDGs) were
conducted and the data collection period was between
March and April, 2014.
Study participants
A total of 34 participants (18 TB patients and 16 HCPs)
were involved from three selected public health facilities
(2 Health Centers and 1 Hospital) in Addis Ababa,
Ethiopia. A total of 11 participants involved in the in-
depth interviews until we reached redundancy and the
rest 23 in the 4 FGDs divided into two sub groups: TB
patients group and HCPs group, categorized by gender.
Interviewed TB patients (IP) were those patients who
visited the three public health facilities for their TB
treatment under DOT during the data collection
period and the HCPs were those with long work ex-
perience and involvement in the management of TB
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patients in the respective public health facilities as DOT
Providers (DP).
Data collection and procedure
All the in-depth interviews and FGDs were conducted
by the principal investigator and a well trained health
officer who served as assistant data collector and was
involved in the facilitation of the data collection pro-
cesses. At the beginning and end of each of the data
collection days we had a debriefing meeting where we
had an opportunity to discuss any issues related to
interviews, these activities had repeated till the end of
the data collection. Individual’s patient and DOT pro-
vider interviews took place in private area inside the
facilities or TB clinics. Prior facility visits were made
to explain about the research objectives and to get
permission from the heads of the respective facilities
to conduct the research and to make arrangements
for data collection purpose.
Each Interview was done using a semi-structured
questionnaire and an interview guide which was de-
veloped by consulting different literatures and na-
tional documents [4, 10]. For the patient group
questions include “perception and experiences related
to DOT”, “Support from family, friends and the com-
munity during their TB treatment” and “Health care
facilities and interactions with HCPs” and for the
health care providers group: “their experiences in pro-
viding DOT”, “Main problems related to observation of
treatment”, “any suggestion for improvements (DOT)”.
These questions were initially developed in English and
translated into Amharic (local language).
Each FGD was conducted in a selected room which
could accommodate the number of participants. Each
session of the FGDs lasted an average of 90 min. A
FGDs Interviews questions and guide were used to initi-
ate discussions and to gear the whole session of the dis-
cussions towards the topic. All sessions of the in-depth
interviews and the FGDs were conducted in Amharic
language and were audio-recorded.
Data analysis data quality assurance
Data analysis was started together with the data col-
lection process. All the audio records of the inter-
views, the FGDs and the field notes were reviewed on
a daily basis. Each of the audio record was repeatedly
listened to and transcribed verbatim and translated
into English by the principal investigator. All the field
notes, transcripts and translations were read repeat-
edly till the investigator becomes familiar with them.
Qualitative data analysis software (Open Code Version
3.5) was employed for the development of coding
based on the original terms used by participants and
this was followed by identifying the most frequently
observed category and the development of emergent
themes.
Ethical considerations
Ethical clearance was obtained from the Institutional
Review Board (IRB) of University of Gondar, from
Addis Ababa city administration health bureau ethical
clearance committee and St Peter TB Specialized hos-
pital ethical clearance board. Prior to each session, a
written description of the study aims and risks of par-
ticipating was provided. Written informed consent to
participate was obtained from each participant of the
study and to ensure participant’s anonymity and
privacy during interviews private areas were used and
following the data collection from each study partici-
pants’ audio records were kept confidential. Each
study subject was identified only by code. Also the
collected data were kept secure with the principal
investigator.
Results
A total of thirty-four participants (18 TB patients and 16
health care providers) were involved in both in-depth in-
terviews and four focus groups (Table 1 and 2). The most
relevant themes identified from the analysis are listed
below and each theme is reported in detail with illustrative
quotes from data.
Table 1 TB patients participated from public health facilities in
Addis Ababa, Ethiopia, March and April /2014
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1) TB patients regard daily facility visits challenging
2) Most TB patients comply with treatment
3) Family support described as vital to continue
treatment
4) DOT in continuations phase was difficult to
implement
5) HCPs reported risk of acquiring MDR-TB
1) TB patients regard daily facility visits challenging
Most TB patients reported that coming daily to the TB
clinic especially in the first two months of treatment was
very difficult and physically demanding and few patients
regard it as unnecessary. This was particularly the case
for the many patients who were severely sick at the time
of initiating treatment. Also majority of the patients
often come the clinic on foot every day due to lack of
money or due to the high cost of transportation. A fe-
male patient described her daily visits experiences to one
the health centre as follows:
“For me coming daily has no benefit because anyone
has to live for him or herself. Actually what they (DOT
providers) think is to prevent the interruption of taking
our medications but there are patients who are bed
ridden and coming here daily would be very
challenging for them . Myself, I have to come here on
foot on daily basis but the road is hilly and exhaustive
and I had to take several rests on my way because I’m
not yet fully recovered and I was discharged from
hospital recently. If I get advices not interrupt my
drugs and given to take at home I would be very
happy and will take my medication strictly” - (IP 1).
All the DOT providers interviewed acknowledged that
application of strict daily DOT for all TB patients was
very challenging to implement due the problems im-
posed to their TB patients. They describe most TB pa-
tients are very poor and less educated with families to
support and coming daily has implications on work, in-
come and social life of patients. They also describe, in
their daily encounters that most patients usually beg
them to give drugs for more days to take at home.
“TB patients come on daily basis to our facility to
take their medications but sometimes very
challenging for them to come daily. We encountered
with TB patients who are very poor and who
support themselves and their families by working as
a daily laborer, these patients usually complain
about coming daily is interfering with their work
and earnings and they have nothing to eat unless
they work on time. Few of the patients are also
working in private organizations and getting
permission from their employer to come to the
facility for their treatment was difficult and for
those reasons it is always difficult for us to
implement DOT strictly for all TB patients and we
sometime give patients with their drugs to take
them at home but we also make them to come in
long interval to check for side effects and other
problems” - (DP 3)
2) Most TB patients comply with treatment
The majority of TB patients interviewed said they wanted
to be cured and one patient said she feels she will die if she
does not take her drug for one day. Most patients also re-
ported that the advice they got from the health care pro-
viders (DOT providers) helped them to continue their
treatment and most patients described the interaction they
had with the DOT provider as positive. Most patients also
reported that DOT providers observe them while swallow-
ing their drug, also stated they get important information
about TB disease, what foods to eat and about side effects
of drugs from their DOT providers. Below is a description
of a male TB patient in continuation phase of treatment.
“I come here daily to take my medications empty
stomach and now on my 4th month of treatment, I’m so
much grateful to the doctor who is working here in the
TB Clinic. You know there was no one like me who
loves to drink alcohol even if being on treatment for TB
but the doctor’s continuous advice helped me to quit
drinking until I finish my treatment. In addition I’m
taking care of myself and will continue my treatment
properly because I accepted the advice “(IP 2)
Few TB patients expressed their concerns and discom-
fort regarding the frequent change of the health care
Table 2 HCPs participated from three public health facilities in
Addis Ababa, Ethiopia, March and April /2014
Characteristics In-depth interview FGDs





Health Center 1 1 12
Health Center 2 1
Public Hospital 2
Professions
BSc /Clinical nurse 2 7
Health officers 2 5
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providers at the TB clinic at different time during the
course of their treatments and they also pointed out they
feel unconfident/uncomfortable with some of the health
care providers: Below is a 28 years old female patients
expressing her feeling regarding encountering of differ-
ent health care providers.
“The current DOT provider in the TB clinic is the
fourth person in the row I encountered since I started
my treatment here. I’m not against and I don’t oppose
the change of the health care providers in the TB clinic
but all of them should be aware of what drugs I’m
taking and I think this should be a must but few of
them ask what drugs I’m taking and they look
confused with the registers and with what drugs to give
to me to take them “(Female FGD participant)
Most health care providers described there is no per-
manent health care provider assigned to work in the TB
clinic rather different health care providers are assigned
on rotation and working for a certain time interval .
Sometimes a health care provider who is not formally
trained on TB management may be obliged to work in
the TB clinic and this could compromise the quality of
the service and the HCPs suggested to the concerned
body to provide training on the management of TB for
all health care providers working in the respective facil-
ities. Below is how a DOT provider described the im-
portance of assigning a permanent staff at the TB clinic
in his facility.
“I strongly suggest assigning of full time dedicated
and permanent staff in the TB clinic who can
consistently offer the TB treatment and also important
information and advice to all TB patients during
their treatment but this is not happening and there is
no full time dedicated TB clinic staff. For instance I
myself not working permanently here in this TB clinic
rather it is additional responsibility beside working in
the OPD and this is a big burden for me and as a
human being I may burn out and loss concentration
and might not treat patients politely and may not
offer them the right information and advice even
sometime I may committee mistakes even quarrel
with patients therefore assigning permanent staff
is I think very important” (DP 2)
3) TB patients feel that the close family support is vital
The majority of TB patients stated they told to and close
family members know their TB status, who in turn pro-
vided them support and encouragement during treatment.
However, few respondents said they often feel stigmatized
by few close friends and neighbors because of a lack of
understanding about TB. Below a female patient de-
scribed the good support from her close families and
the discomfort regarding her interaction with old
friends and what another male TB patient told:
“My family all of them including my mother and
sisters are supportive when I was admitted at “Samba
nekersa” (local hospital) they never get far away from
my side. They were always available at the time of
need especially my mom she always weak up early in
the morning to remind me to come here (TB Clinic)
I’m really thankful for her support. But regarding
neighbors they put a big pressure on me when I say
pressure they keep distant from me including my
childhood friends with whom I used to hang and play
but I understand them all it is because of their fear
but as far as I’m taking my drugs after 15 days I
cannot transmits TB to them that is what the doctors
told me. I also take care not to infect others I always
covers my mouths and nose whenever I’m coughing
“(IP 3).
“I told to my close friends about my TB disease and
other people around my neighborhood also know
about my conditions but nobody comes to my home to
ask and to talk to me except very few close friends who
used to encourage me saying ‘Egiziabiher yimarih’(May
God cure you) when they met me outside . I don’t
complain much and I accepted the situations and I
always pray crying and tells to my God “(IP 4)
Most of the health care providers interviewed also
expressed TB patients are stigmatize due to lack of
knowledge and awareness about TB by the community.
The health care provider recommended TB related edu-
cation should be continuously done by different means
and Medias including through radio, Television, posters
and leaflets. One health care provider participated in
one of the focus group underlined the importance of giv-
ing educations to the community including testimonials
by cured TB patients.
“I myself don’t want to use the bus serving around
this facility because MDR-TB patients are using it to
travel to the hospital to get their treatments. The bus
is also known by the nick name MDR- bus and if you
see this bus it is always full of people and the
passengers don’t want to open any of the windows due
to the fear of ‘bird’ (Cold air) and if you are inside the
bus and you wanted to open the windows you cannot
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open any of them because many of the windows
are deactivated to be un open able for the purpose of
posting an advertisements” (Male HCPs FGD
participant).
4) No DOT in continuation phase
The national TB program introduced the RH containing
regimen in the continuation phase of TB treatment al-
though recommended treatment procedure is DOT for the
whole course and duration of treatment including in the
continuation phase but most of the health care providers
reported DOT is not implemented as recommended.
Most stated that they are aware of and were trained
on the six month RH containing treatment regimen
which should be provided under strict observation of all
TB patients for the whole duration of their treatments
but this was very difficult to implement mainly due to
problems and challenges impose on their TB patients.
DOT could have been done at the community level but
there was no established mechanism to work with the
Health Extension Workers (HEWs) or other community
members who can serve as TB TTS and observe patients
while taking their medications in their home. Below is
how a DOT provider and a female health professional
participant of focus groups describe the importance of
DOT and the challenges related to implementing super-
vised treatment for six months.
“I suggest DOT should be implemented for the whole
course of six months for all TB patients but there are
several problems to do that. For example few TB
patients are government employee which is very
difficult for them to get permission or sick leave to
come here daily for their treatments and there are also
few private employed patients who will not be able to
get any permission and even they may be fired if
known to have TB disease by their employer. For those
reason it is a usual encounter that TB patients always
put big pressure on us to give them their medication to
taking them medication at their home. These are what
patients usually tell and this is the idea they present
often and it is difficult.” (DP 1).
“DOT for TB treatment is always a controversy for me
because TB patients always argue with us not to come
every day particularly those patients who are students
they always beg us to give them drugs for more days to
take at home and I know long time ago TB was
recognized as dangerous disease and the DOT
program was introduced as means of treatment
delivery for TB patients but some patients pressurized
us mentioning they know about the disease seriousness
and the importance of taking their medication and if
given they can take it at home . Few also tell us they
encounter with big social problem and beg us to give
them drugs for more days and we give them. I know
from the point of preventing the generation of MDR-
TB DOT is very important but it is difficult from
patients perspectives” (Female FGD participant)
5) Health care providers reported risk of MDR-TB
The risk of TB/ MDR-TB transmission from patients
to healthcare workers was a major issue raised by all the
participants. To the providers, TB infection especially
MDR-TB represents a serious concern for most. The
two health centers in study are MDR-TB treatment
follow-up center (TFC) and the hospital is an MDR-TB
treatment initiating center (TIC) and the HCPs stated
they felt and are concerned that this might put them at
increased risk of acquiring TB/MDR-TB from patients,
though there was no health care provider reported with
MDR-TB diagnosed. Below is how one health profes-
sional working in one of the health center describes her
and another colleague’s concern about work at a TB
clinic.
“Safety and protecting the HCPs working here (TB
Clinic) is very concerning, as you know these days
MDR TB is coming into the picture and I don’t
perceive much is being done to protect the HCPs who
are assigned and working the TB clinic. These days it
is becoming hard to get a health care provider who is
willing to work in a TB clinic because of the risk and
fear acquitting TB/MDR-TB and I think this issue
must be thoroughly investigated and considered”
(Female FGD Participant).
“The TB clinic is below the standard, the roof height is
short, the door and the windows should be easily open
able and in opposite position these all are not in place
as you can see. This will definitely expose us to
infection. We are working here to help patients and
this has to be corrected, imagine yourself working in
this room and condition this is very risky and for us
this is a big problem “. (DP 3)
Discussion
In this study most participants reported that making a daily
visit to health facility for DOT was difficult due to the dis-
tance of the facilities from their residences, lack of or high
transportation cost and had undesired implications on their
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work and social lives. TB patients need to overcome many
of these challenges to comply with TB treatment on a daily
basis although most TB patients do comply with treatment
because they wanted to be cured and the advices from their
DOT providers and close family supports were also import-
ant for most TB patients. HCPs also indicated the difficul-
ties of implementing facility based DOT mainly due the
implication it had on their TB patients and stated DOT
had not always been implemented for the full course as rec-
ommended also reported deep concern regarding risk of
acquiring MDR-TB while working in the TB clinics.
The national TB program has introduced the 6-
month TB treatment regimen containing RH in the con-
tinuation phase, this regimen has several benefits, it has
a lower rate of treatment failure and relapse and it
shortens the total duration TB treatment and could in-
crease patient’s compliance and adherence [2]. But the
most important disadvantage of this regimen is the pos-
sibility of development of Rifampicin resistant TB in pa-
tients with poor adherence and MDR-TB could increase
if strict DOT is not followed for the full course of treat-
ment [4, 10].
In this study we found that in all the three public health
facilities DOT was not implemented in continuation phase
of TB patient’s treatment because of the challenges and
difficulties imposed on the TB patients. Daily facility visits
for DOT during the intensive phase was not acceptable by
most of the TB patients and has several implications on
their work, family and social lives and it was unrealistic
for the DOT providers to make the whole course of the
TB treatment under DOT. The Ethiopian national TB
guideline suggest that DOT could be implemented in dif-
ferent settings not only in a health facility but also at pa-
tients home and could be done by HEWs or other trained
community members who could observe patients while
taking their medications down in the community [3, 4].
This approach was found to be more cost effective and ef-
ficient in rural Bangladesh as compared to facility based
DOT. But in this study DOT was not yet established at
the community level and across the three facilities and it
seems very important for the national TB program to
established a mechanism to make sure DOT is imple-
mented for entire period of TB treatment in all settings
otherwise the risk of MDR-TB could potentially exists if
adherence to treatment cannot be verify.
For treatment adherence personal characteristics of
patients like the knowledge, motivations and perceptions
about disease are important determinant factors for ad-
herence to treatment [13]. TB related information,
health education, and consultation by the DOT provider
for patients could help to increase the knowledge and
understanding of the TB patients about their disease
condition could motivate them to adhere to their treat-
ment [14]. The support from the family and community
is also very important for patients to comply with their
treatment. These supports could be financial or psycho-
logical. Most of the TB patients in this study comply
with treatment despite the several challenges they are
facing, because they wanted to be cured this could indi-
cate the importance of individual TB patient under-
standing, determination and motivation to complete
treatment. Also health care providers, families and the
community could play a vital role in encouraging and
supporting TB patients to comply with treatment strat-
egy to increase the knowledge and awareness of TB pa-
tient’s family and the community about TB should be
important activity for a TB control program.
Facility based daily DOT was associated with several
challenges and with implications on patients in terms of
their work, social and family lives but despite those chal-
lenges TB patients in this study still wanted to continue
with their treatment because they wanted to be cured
and the advice,encouragement and support from both
the DOT providers and family were also important for
continuing of their TB treatments and these findings
were similar with a study conducted in Addis Ababa
found that despite several challenges a large group of pa-
tients still managed to continue treatment, mainly be-
cause relatives or community members provided food,
encouragement and sometimes money for transport [15]
another qualitative study conducted among TB/HIV co-
infected patients found that factors that influenced ad-
herence to TB treatment positively were beliefs in the
curability of TB, beliefs in the severity of TB in the pres-
ence of HIV infection and support from families and
health professionals [16]. All patients of a qualitative
study conducted in northern Ethiopia, reported the first
two months of treatments were physically exhausting
and geographical access to health care facilities and fi-
nancial burdens were factors the most influenced timely
TB treatment initiation and compliance [17].
Health care providers shared deep concern regarding
risk of acquiring MDR- TB from patients while working
as DOT provider in the TB clinics found in the three fa-
cilities included in this study. They felt their own vulner-
ability as first line service providers for TB and MDR-TB
patients in the absence of standard TB infection control
measures in the respective TB clinics. This could be due
to the fact that all the three TB clinics in this study are
also providing treatment services for MDR-TB patients.
The health care providers suggested many strategies for
improvement at the local level including implementing
standard TB infection control measure in TB clinics,
training of all health care providers on MDR-TB and de-
sign a motivation and recognition system for health care
providers working TB and MDR-TB areas.
In this way, the study also indicated how facility based
TB treatment supervision was very difficult to implement
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especially from patient’s point of view but if the system
could be established the observation of TB treatment
could have be done in different settings including at home
not necessary by health care provider but also by HEWs
and other TTSs for the whole six months of treatments
and the national TB program in Ethiopia has started to
decentralized TB care services beyond health facilities to
make it more accessible to the community. TB treatment
is being provided under observation by HEWs and TB
treatment supporters in different settings including at
home [4]. Related to this finding, a study conducted in
southern Ethiopia has shown the involvement of HEWs in
treatment observation at health posts improved treatment
success rate [18] and this could be applied in different set-
tings to ease the challenges and difficulties of patients in
accessing health facility for DOT.
Limitations of the study
In this study, TB treatment data was not reviewed. In
this way, it was not possible to compare the patient and
worker's lines. In addition, we did not observed the way
that DOT is offered in the respective facilities.
Conclusions
This study highlighted the several challenges and diffi-
culties surrounding a facility based DOT as a method of
TB treatment supervision in public health facilities in
Addis Ababa. DOT was not being implemented for the
full course of treatment particularly during the continu-
ation phase of TB treatment as recommended by the
National TB program (NTP) and this may have a risk
for an increase in patients’ non compliance which is a
major cause of development of MDR TB. The challenges
and difficulties identified in this study may be indicative
of situation in other Health facilities in Addis Ababa as
well as elsewhere in the country.
Hence the NTP has to explore or do further researches
on how best could the TB treatment delivery options im-
proved to ensure adequate treatment adherences and
minimize the negative implications of the daily burden im-
posed by the facility based DOT on TB patients. A more
patient-centered approach could be introduced and
strengthened by further decentralizing the DOT to the
community level in order to ensure adherence of TB pa-
tients to their treatment. In addition, a system should be
established to ensure the involvement of the community
and family in TB prevention and control efforts as TB
Treatment Supporters and the Health Care Providers con-
cerns about the risk of acquiring MDR-TB while working
in TB clinics should be further studied and addressed.
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